Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
66.00    0.00 (0.00%)
Bid:
65.60
Ask:
70.00
Spread: 4.40 (6.707%)
Market Cap: £89.08m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Q3 Trading Update

24 Feb 2022 07:00

RNS Number : 6370C
Trifast PLC
24 February 2022
 

 

 

 

 

Trifast plc

(Trifast, or Group)

 

"Innovation today to build a better tomorrow - Growing sustainably together"

 

Q3 Trading update

 

London, Thursday, 24 February 2022: Trifast plc (LSE Main market premium listing: symbol: TRI), leading international specialist in the design, engineering, manufacture, and distribution of high-quality industrial fastenings and Category 'C' components principally to major global assembly industries, issues the following unaudited Q3 Trading Update for the period 1 October 2021 to 31 December 2021.

Mark Belton, Chief Executive Officer commented:

"Looking beyond the current period of macroeconomic challenge, Trifast has one clear aspiration - to become a much bigger, more profitable company than the one we are today. I would like to thank all of our teams for their ongoing support and dedication as we work together to turn that aspiration into a reality"

 

TRADING UPDATE

Following on from >30% year-on-year growth in HY1 (at constant exchange rate; against HY2020: growth of 3.2%), we have continued to see underlying demand across all of our key markets with the Group's monthly revenues showing consistent year-on-year growth, even as set against the record trading recovery levels we saw in Q3 of FY2021.

 

We have seen very strong performances in particular from our distributor trading in the UK, Europe and out of Taiwan, new light vehicle platform wins in the USA and robust energy, tech and infrastructure growth in Hungary. In conjunction with strong Q3 trading from our recent acquisition, TR Falcon, these have more than offset continued short-term market disruption in some segments. Whilst we have continued to outperform light vehicle production in the YTD period, semi-conductor chip shortages have held back volumes behind prior year in Europe and the UK. In addition, December floods in Malaysia, coupled with specific sub-contractor transfer issues at a key health and home customer, have temporarily reduced trading in the Asia region.

 

Supply chain challenges remain and although raw material and freight costs, as well as lead times, are now stabilising across most of the world, these continue to stand at historically high levels. As a result of these ongoing challenges, the business has continued to invest in inventory levels in HY2, to ensure reliability of supply. This uplift is expected to reverse as the macroenvironment settles.

 

Our price increase programme continues to progress at pace, with the majority of first phase negotiations now successfully completed and the remainder expected to be concluded in the coming weeks. Price negotiations form an ongoing part of doing business, especially as inflationary pressures persist, including the recent well-publicised increases to energy and salary costs which we expect to impact pricing throughout the supply chain.

 

AREAS OF STRATEGIC FOCUS

· Project Atlas

Project Atlas, a key driver of future growth and cost efficiencies continues to progress, with a phased roll-out to our largest trading subsidiary underway. We look forward to providing further details of our progress in due course.

 

· Acquisitions

Our latest US acquisition, TR Falcon (August 2021) is integrating well and contributing positively to the Group's results. We are pleased to report that our pipeline of targets continues to build in North America and beyond, with a number of exciting opportunities at different stages of the process.

 

OUTLOOK

Despite the ongoing unpredictability in the macroeconomic environment, the long-term fundamentals of our business model and strategy remain unchanged. Through continued focus on service levels and responsiveness we have strengthened the Group's position in its established markets during this challenging period and we continue to see exciting opportunities in high growth/emerging technologies, including in the Electric Vehicle (EV) space, where our secured order pipeline has never been stronger. With strong momentum in contract wins, new order pipeline and general activity levels, the Board is confident in the Group's outlook, with its full year FY2022 expectations unchanged.

 

 

 

Further enquiries please contact:

Trifast plc

Jonathan Shearman, Non-Executive Chair

Mark Belton, Chief Executive Officer

Clare Foster, Chief Financial Officer

Tel: +44 (0) 1825 747630

Email: corporate.enquiries@trifast.com

 

Peel Hunt LLP (Stockbroker & financial adviser)

Mike Bell

Tel: +44 (0) 20 7418 8900

 

TooleyStreet Communications, (IR & media relations)

Fiona Tooley

Tel: +44 (0)7785 703523

Email: fiona@tooleystreet.com

 

 

 

Editors' notes

About Trifast plc

Trifast (TR) is a leading international specialist in the design, engineering, manufacture, and distribution of high-quality industrial fastenings and Category 'C' components principally to major global assembly industries.

 

TR supplies to c. 5,000 customers in c.75 countries across a wide range of industries, including Light vehicle, Heavy vehicle, Health & Home, Energy, Tech and Infrastructure (ET&I), General industrial and Distributors. As a full-service provider to multinational OEMs and Tier 1 companies spanning several sectors, TR delivers comprehensive support to its customers from concept design through to technical engineering consultancy, manufacturing, supply management and global logistics.

 

TR employs c.1,300 people across 34 business locations within the UK, Asia, Europe, and the USA including seven high-volume, high-quality and cost-effective manufacturing sites and three technical & innovation centres across the world.

 

 

"Innovation today to build a better tomorrow - Growing sustainably together"

 

For more information, visit

Investor website: www.trifast.com

Commercial website: www.trfastenings.com

LinkedIn: www.linkedin.com/company/tr-fastenings

Twitter: www.twitter.com/trfastenings

Facebook: www.facebook.com/trfastenings

 

Note

Trifast, TR and TR Fastenings are registered trademarks of the Company.

 

LEI number: 213800WFIVE6RUK3CR22

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGAPUPPPGW
Date   Source Headline
3rd Jun 20267:46 amRNSDirector Declaration
5th May 20261:03 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSTrading Statement
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20261:44 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSHolding(s) in Company
27th Mar 20262:53 pmRNSHolding(s) in Company
27th Mar 20262:43 pmRNSDirector/PDMR Shareholding
17th Feb 20261:15 pmRNSDirector/PDMR Shareholding
16th Feb 20263:02 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTrading Statement
19th Jan 20268:34 amRNSDirector Declaration
9th Jan 202611:02 amRNSDirector/PDMR Shareholding
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSHalf-year Financial Report
23rd Oct 20255:10 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSTrading Statement
15th Oct 20253:06 pmRNSDirector/PDMR Shareholding
7th Oct 20259:01 amRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNSBoard Fellow Appointment
11th Sep 20251:31 pmRNSResult of AGM
11th Sep 20257:00 amRNSTrading Statement
5th Sep 20253:00 pmRNSDirector/PDMR Shareholding
18th Aug 20251:21 pmRNSDirector/PDMR Shareholding
28th Jul 20253:19 pmRNSDirector/PDMR Shareholding
22nd Jul 20258:08 amRNSNotice of AGM
14th Jul 20251:44 pmRNSDirector/PDMR Shareholding - Replacement
14th Jul 20251:17 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSFinal Results
27th Jun 20252:50 pmRNSNotice of Results
4th Jun 20257:00 amRNSTotal Voting Rights
19th May 20255:02 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Update & Notice of FY25 Annual Results
16th Apr 20253:02 pmRNSShare purchases under Dividend Re-Investment Plan
11th Apr 20257:00 amRNSDirector/PDMRs share purchases
2nd Apr 20251:25 pmRNSBlock listing Interim Review
27th Mar 20252:15 pmRNSDirector/PDMR Shareholding
24th Mar 202512:12 pmRNSDirector/PDMR Shareholding - Purchase of Shares
13th Feb 20257:00 amRNSTrading update
5th Feb 202511:19 amRNSDirector/PDMR Shareholding
4th Feb 20253:54 pmRNSDirector/PDMR Shareholding
28th Jan 20252:07 pmRNSDirector/PDMR Shareholding
27th Jan 20255:15 pmRNSDirector/PDMR Shareholding
23rd Jan 20255:27 pmRNSHolding(s) in Company
11th Dec 20241:58 pmRNSHolding(s) in Company
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding
10th Dec 20243:23 pmRNSTotal Voting Rights
29th Nov 202411:15 amRNSChange of Auditor & Registered office address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.